ArticleThe Lancet regional health. Western Pacific2023

Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trial.

Masaaki Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.